Anti TNF-α neurological syndromes
Evidence-based neurology checklist on anti tnf-α neurological syndromes: TNFα inhibitor drugs Adalimumab Certolizumab Etanercept Golimumab Infliximab Central nervous system presentations Peripheral nervous system presentations Magnetic resonance imaging (MRI) features Cerebrospinal fluid (CSF)…
TNFα inhibitor drugs
- Adalimumab
- Certolizumab
- Etanercept
- Golimumab
- Infliximab
Central nervous system presentations
Peripheral nervous system presentations
Magnetic resonance imaging (MRI) features
Cerebrospinal fluid (CSF) analysis
Neurophysiology
Treatment
References
- Ali F, Laughlin RS. Asymptomatic CNS demyelination related to TNF-α inhibitor therapy. Neurol Neuroimmunol Neuroinflamm 2016; 4:e298.
- Seror R, Richez C, Sordet C, et al; Club Rhumatismes et Inflammation Section of the SFR. Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey. Rheumatology (Oxford) 2013; 52:868-874.
- Tejera-Segura B, Ferraz-Amaro I. Biological therapy and neurological manifestations. What do we know? Reumatol Clin 2016; pii: S1699-258X(16)30042-0 ([Epub ahead of print).
- Li SY, Birnbaum AD, Goldstein DA. Optic neuritis associated with adalimumab in the treatment of uveitis. Ocul Immunol Inflamm 2010; 18:475-481.
- Fockaert N, Goffin K, Demaerel P, Van Paesschen W. Infliximab-associated autoimmune limbic encephalitis: a case report. Acta Neurol Belg 2015; 115:161-163.
- And 5 more. Subscribe to see the full list
